Coordinated MD-SD-OCT, a double-technology medical device for corneal diseases, and contributed imaging hardware to VEMoS.
COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL
Italian SME manufacturer of ophthalmic diagnostic instruments — corneal topographers, tomographers, aberrometers and OCT — now extending into AI-based refractive surgery planning.
Their core work
CSO is an Italian manufacturer of ophthalmic diagnostic instruments — the machines eye doctors use to image the cornea, measure the optics of the eye, and plan surgery. Their product family includes corneal topographers, tomographers, aberrometers, and OCT-based imaging systems used in clinics worldwide for diagnosing corneal disease and preparing refractive procedures like LASIK and SMILE. Their H2020 work has pushed these instruments from standalone diagnostic devices toward integrated platforms that feed patient data into simulation and surgical-planning software. In short: they build the hardware that measures eyes, and they are now extending it with predictive software for surgery outcomes.
What they specialise in
VEMoS built a virtual eye model for personalised LASIK/SMILE treatment planning using CSO's diagnostic data.
VEMoS explicitly combines open-field aberrometer, topographer and tomographer outputs — CSO's core instrument portfolio.
Keywords from VEMoS cover monofocal and multifocal IOLs and post-operative simulation.
VEMoS keywords include neural network and post-operative simulation, signalling a move toward predictive software.
How they've shifted over time
In 2015-2017, through MD-SD-OCT, CSO focused on building diagnostic hardware — specifically a dual-technology OCT device for imaging corneal disease, where they were confident enough to lead the consortium. From 2019 onward, their VEMoS participation shows a clear shift from pure hardware into software and AI: using their topographer, tomographer and aberrometer data as inputs to a neural-network-driven virtual eye model that simulates surgical outcomes. The trajectory is hardware-first → data-and-simulation layer on top of that hardware.
They are moving from selling instruments to selling instrument-plus-software platforms, which makes them an interesting partner for anyone building clinical decision support in ophthalmology.
How they like to work
CSO has shown both modes: leading a consortium when the project is centred on their own device (MD-SD-OCT) and joining as a specialist hardware partner when the project is larger and software-led (VEMoS). Their consortia have been compact — six unique partners across three countries over two projects — which suggests they prefer focused, tightly-scoped collaborations over sprawling networks. Expect a hands-on technical partner who brings real instruments, not just requirements.
Small, focused network of six partners across three countries over two H2020 projects. Strongly Italy-anchored, with limited but targeted European reach centred on ophthalmic clinical and engineering partners.
What sets them apart
Unlike research groups that publish papers or software houses that only model eyes, CSO actually builds and sells the diagnostic instruments sitting in eye clinics — topographers, tomographers, aberrometers and OCT devices. That means a partner can get both a measurement tool and a route to market through CSO's existing clinical customer base. For an SME they have credibility as a coordinator (EUR 1.97M IA project under their lead) and are now extending into the software and AI layer rather than staying a pure hardware vendor.
Highlights from their portfolio
- MD-SD-OCTTheir largest project (EUR 1.97M) and the one where they led the consortium — a rare SME coordinator role in a Health Innovation Action.
- VEMoSMarks their pivot from hardware-only to AI-based surgery simulation, combining their full instrument stack with neural-network outcome prediction.